Skip to main content

Day: March 9, 2026

Controlled Thermal Resources and Plum Acquisition Corp. IV Announce Definitive Business Combination Agreement to Advance U.S. Critical Minerals and Energy

As one of America’s largest and most advanced geothermal power and critical minerals projects, the transaction is expected to enable Controlled Thermal Resources to advance its Hell’s Kitchen Project and commence Stage 1 construction. Transaction values Controlled Thermal Resources at a pro forma enterprise value of approximately $4.7 billion.IMPERIAL, Calif., March 09, 2026 (GLOBE NEWSWIRE) — Controlled Thermal Resources Holdings Inc. (“CTR” or the “Company”), an emerging leader in U.S. critical minerals and clean geothermal energy development, and Plum Acquisition Corp. IV (Nasdaq: PLMK, “Plum IV”), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”) that will result in CTR becoming a publicly...

Continue reading

Schouw & Co. share buy-back programme, week 10 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 27 February 2026 81,283 678.18 55,124,691    Monday, 2 March 2026 1,000 670.00 670,000    Tuesday, 3 March 2026 1,000 651.00 651,000    Wednesday, 4 March 2026 1,000 647.00 647,000    Thursday, 5 March 2026 1,000 615.00 615,000    Friday,...

Continue reading

New American Drone and Defense Company to be Created Through Merger of Powerus and Aureus Greenway Holdings

–  Notable Investors of Combined Company Include American Venture Partners Eric Trump and Donald Trump Jr.; Additional Support from Leading U.S. Drone Manufacturer Unusual Machines (“UMAC”) and a Strategic $50 Million Investment –  Combination Advances American Domination of Drone Industry and Autonomous Systems Innovation WEST PALM BEACH, Fla., March 09, 2026 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (Nasdaq: AGH) today announced that AGH and Autonomous Power Corporation, doing business as Powerus (www.Power.us), a company co-founded by former U.S. Army Special Operations veterans that builds and scales autonomous drone systems for military and commercial use in high-risk environments, have entered into a definitive merger agreement. Upon completion of the merger, the combined company will operate under the...

Continue reading

Jeffs’ Brands: KeepZone AI Enters into Channel Partner Agreement for 4G/5G Infrastructure

Agreement Provides for Sale and Promotion of Private Communications Solutions in Ecuador Tel Aviv, Israel, March 09, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data‑driven company expanding into the global homeland security sector through advanced artificial intelligence (“AI”)‑driven solutions, today announced that its wholly‑owned subsidiary, KeepZone AI Inc. (“KeepZone”), has entered into a channel partner agreement (the “Agreement”) with TDCOMM Ltd. (“TDCOMM”) , a provider of next‑generation private LTE and 5G wireless network solutions. Under the terms of the Agreement, KeepZone has been appointed as a distributor for TDCOMM’s private wireless network solutions in Ecuador,  with the ability to expand into additional territories on a case-by-case basis upon mutual...

Continue reading

Safe Harbor Financial CEO Highlights Growth Platform Launch, Debt Elimination, and Financial Stabilization in Letter to Shareholders

DENVER, March 09, 2026 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, today released a letter to shareholders from Terrance Mendez, Chief Executive Officer of Safe Harbor. Dear Fellow Shareholders, Today, Safe Harbor has a strong financial base and is ready to grow: we are debt-free, hold more than $6 million in cash, and have secured a long-term agreement with a major customer that is expected to generate at least $10.5 million in incremental cash flow. Here is a summary of the past year and why we believe the next chapter is significantly more valuable than the last. The Numbers Tell the Story The single most important thing I...

Continue reading

FuelCell Energy Delivers Strong Q1’26 Revenue Growth vs Q1’25; Advances Data Center Power Strategy

DANBURY, Conn., March 09, 2026 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (NASDAQ: FCEL) today reported financial results for its first quarter ended January 31, 2026. First Quarter Fiscal 2026 Highlights (All comparisons are year-over-year unless otherwise noted)Revenue of $30.5 million, compared to $19.0 million, an increase of approximately 61% Gross loss of $(5.9) million, compared to $(5.2) million, an increase of approximately 13% Loss from operations of $(26.3) million, compared with $(32.9) million, a decrease of approximately 20% Net loss per share attributable to common stockholders was $(0.49), compared with $(1.42) Backlog of $1.17 billion, compared to $1.31 billion, a decrease of approximately 10.8%“During the first fiscal quarter, we delivered strong revenue growth, sharpened operating discipline, and strengthened...

Continue reading

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) and cervical cancer CRB-701 data for both indications is expected in mid-2026 with focus on durability and patient stratification Reported 14-day CRB-913 SAD/MAD data demonstrating potent and rapid weight loss of 2.9% with favorable GI safety On schedule to complete 12-week CRB-913 obesity study (n=240) in summer 2026  Completed $75 million public offering in Q4 2025 extending cash runway into 2028  NORWOOD, Mass., March 09, 2026 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage company focused on promising new therapies in oncology and obesity, today provided a corporate update and reported financial results for the fourth quarter and year...

Continue reading

Nayax Reports Fourth Quarter and Full Year 2025 Results 

Full year revenue of $400.4 million, recurring revenue growth of 29%Full year organic revenue growth of 24% (1)Net income of $35.5 million with Adjusted EBITDA of $61.1 million (1)2026 Revenue guidance of $510 million – $520 million2026 Adjusted EBITDA(1) guidance of $85 million – $90 million  HERZLIYA, Israel, March 09, 2026 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX, TASE: NYAX), a global commerce payments and loyalty platform designed to help merchants scale their business, today announced its financial results for the fourth quarter and year ended December 31, 2025. “Nayax delivered strong 2025 results and a very solid fourth quarter. We generated net income of $35.5 million compared to a loss just one year ago, a milestone that reflects the true earnings power of our business model. The company continued to scale...

Continue reading

Tevogen Names Leadership Team to Execute Diversified Growth Strategy

WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the appointment of interim leaders across its core business verticals to execute the first phase of its diversified growth strategy. In this first phase, Tevogen is evaluating strategic opportunities that, if completed, are expected to operate as subsidiaries of the Company and could collectively generate annual revenues exceeding $50 million. The Company expects these transactions to close by the second quarter of 2026, subject to customary due diligence and definitive agreements. Leadership Designations:Digital Health: Arpita Patel and Wojtek Stobinski Generics: Sadiq Khan and David Banko Contract Research: William Keane Biotech: Lori Grosso Artificial Intelligence: Mittul MehtaAbout Tevogen Tevogen...

Continue reading

No. 6/2026 – CeMat A/S acquires right of perpetual usufruct to land plot in Bielany, Warsaw

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6DK-1067 Copenhagen K    Copenhagen, 9 March 2026ANNOUNCEMENT no. 6/2026CeMat A/S acquires right of perpetual usufruct to land plot in Bielany, Warsaw CeMat A/S is pleased to announce that it has obtained a binding decision confirming its acquisition by law of the right of perpetual usufruct (RPU) to 75% of the shares in a plot of land designated for road use on Wólczyńska Street, in the Bielany district of Warsaw. The decision relates to a land plot covering a total area of 800 sqm, and grants the company the right of perpetual usufruct until 2089. This binding decision provides the legal basis for registering the RPU in the land and mortgage register. The acquired plot completes the entire internal road network within...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.